Pipeline Perspectives: Mapping the Biosimilar Landscape
The biosimilar pipeline analysis market involves products such as monoclonal antibodies, insulin, granulocyte colony-stimulating factor, interferons, erythropoietin, and others. Biosimilar versions offer significant cost savings compared to their reference biologics, expanding patient access to lifesaving biologic treatments. Biosimilars also represent an opportunity for biopharmaceutical...
0 Comments
0 Shares
French (Français)
Spanish (Español)
Arabic
Portuguese (Português)
Deutsch
Turkish (Türk)
Dutch (Nederlands)
Italiano
Romaian (Română)
Português (Brasil)
Greek (Ελληνικά)
Russian (русский)